Abstract
In-hospital production of affordable medicines holds potential to address problems of drug accessibility. However, expanding the scope of magistral preparation to include high-cost drugs and complex biologicals gives rise to new challenges. We discuss ethical and regulatory complexities faced by Dutch initiatives defying the current pharmaceutical system through magistral preparation.
| Original language | English |
|---|---|
| Pages (from-to) | 1045-1047 |
| Number of pages | 3 |
| Journal | Trends in biotechnology |
| Volume | 38 |
| Issue number | 10 |
| Early online date | 31 Oct 2019 |
| DOIs | |
| Publication status | Published - Oct 2020 |
Keywords
- disruptive innovation
- ethics
- in-hospital production
- magistral preparation
- regulatory science
Fingerprint
Dive into the research topics of 'In-Hospital Production of Medicines: Preparing for Disruption'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver